Conflicting classifications of pathogenicity
Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 9 submitters
gnomAD v4.1
Rare
rare (popmax 0.1%, afr)
Conditions
1
oculocutaneous albinism type 2
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 3.4 | GERP -1.5, phastCons 1 |
| Overall | ||
| CADD | 3.495 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
gnomAD v4.1 · exomes + genomes
Grpmax group
0.1%
African / African-American · 75/74,984 alleles
Filtering AF
0.0817%
ClinGen BA1/BS1 input
FAF95, joint · FAF99 0.0751%
Overall
0.0552%
889/1,611,848 alleles · rare
exomes 789/1,459,542 · genomes 100/152,306 · joint denominator
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.1% | 1,000 |
| European (non-Finnish) | 0.0642% | 1,558 |
| Remaining individualsnot grpmax-eligible | 0.0288% | 3,468 |
| Finnishnot grpmax-eligible | 0.0219% | 4,574 |
| South Asian | 0.0165% | 6,067 |
| East Asian | 0.0134% | 7,478 |
| Admixed American | 0.00833% | 12,004 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- OCA2
- Protein
- p.Asp619=
- Coding
- c.1857C>T
- MANE Select
- NM_000275
- dbSNP
- rs7164127
- Type
- single nucleotide variant
- Location
- chr15:27951878 (GRCh38)
- Gene constraint
- LOEUF 0.869 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 73.79
Disease context
oculocutaneous albinism type 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Oculocutaneous albinism type 2 (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
- Prevalence
- 6-9 / 10 000 (Specific population)
Similar variants
- OCA2 p.Asp619Val Likely pathogenic ★ same residue
- OCA2 c.1044+1G>T Pathogenic ★★ same condition
- OCA2 c.1045-15T>G Pathogenic/Likely pathogenic ★★ same condition
- OCA2 c.1182+1G>A Pathogenic ★★ same condition
- OCA2 c.1365-1G>A Pathogenic ★★ same condition
- OCA2 c.1503+5G>A Pathogenic/Likely pathogenic ★★ same condition
- OCA2 c.1504-2A>G Pathogenic/Likely pathogenic ★★ same condition
- OCA2 c.1842+1G>T Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/oca2-p-asp619 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown